샘플 요청 목록

 카트 문의
시장보고서
상품코드
1765150

세계의 말초혈관 기기 시장

Peripheral Vascular Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 192 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말초혈관 기기 세계 시장은 2030년까지 160억 달러에 이를 전망

2024년에 127억 달러로 추정되는 말초혈관 기기 세계 시장은 분석 기간인 2024-2030년 CAGR 4.0%로 성장하여 2030년에는 160억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 혈관성형술 스텐트는 CAGR 4.6%를 나타내고, 분석 기간 종료시에는 91억 달러에 이를 것으로 예측됩니다. 혈관성형술 풍선 부문의 성장률은 분석 기간중 CAGR 3.6%로 추정됩니다.

미국 시장은 34억 달러, 중국은 CAGR 3.6%를 보일 것으로 예측

미국의 말초혈관 기기 시장은 2024년에 34억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 25억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 3.6%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.7%와 3.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%를 보일 전망입니다.

세계의 말초혈관 기기 시장 - 주요 동향과 촉진요인 정리

말초혈관 기기가 현대 의료에 필수적인 이유는 무엇일까?

말초혈관 기기는 심장이나 뇌를 제외한 동맥, 정맥, 림프관 등 말초혈관에 영향을 미치는 질환의 진단과 치료에 필수적인 도구입니다. 스텐트, 카테터, 풍선, 필터 등을 포함한 이들 장치는 말초동맥질환(PAD), 심부정맥혈전증(DVT), 만성정맥부전(CVI) 등의 질환을 관리하기 위해 사용됩니다. 이러한 기기의 중요성은 적절한 혈류를 회복하고, 합병증 위험을 줄이고, 환자의 결과를 개선하는 능력에 있습니다. 예를 들어, 혈관 성형술용 풍선이나 스텐트는 좁아지거나 막힌 동맥을 열어 혈액 순환을 촉진하고 조직 손상을 방지하기 위해 활용됩니다. 이러한 기구를 이용한 최소침습적 시술의 개발은 혈관 수술에 혁명을 가져왔으며, 회복 시간을 단축하고 환자의 삶의 질을 향상시켰습니다.

기술의 발전은 어떻게 말초 혈관 기기를 형성하고 있는가?

기술의 발전은 말초혈관 기기의 기능과 효능을 크게 향상시키고 있습니다. 재협착을 방지하기 위해 약물을 방출하는 약물 용출성 스텐트, 혈류를 회복시킨 후 서서히 용해되는 생체 흡수성 스텐트 등의 혁신적인 치료법은 혈관 치료의 중요한 돌파구입니다. 또한, 혈관 내 초음파(IVUS), 광간섭단층촬영(OCT) 등 영상진단 기술의 발전으로 스텐트 삽입의 정확도와 혈관 상태 평가가 향상되고 있습니다. 형상기억합금 및 생체적합성 폴리머와 같은 첨단 소재의 통합은 이러한 장치의 내구성과 성능을 향상시키고 있습니다. 또한, 약물 전달 및 기계적 지지와 같은 여러 기능을 결합한 하이브리드 디바이스의 개발로 임상의가 사용할 수 있는 치료 옵션이 확대되고 있습니다. 이러한 기술 발전은 치료를 보다 안전하고, 효과적이며, 덜 침습적인 치료로 만들어주고 있습니다.

말초혈관 기기의 주요 용도는?

말초혈관 기기는 다양한 의료 분야에 광범위하게 적용되고 있습니다. 중재적 심장학에서 이러한 기기는 PAD 치료에 사용되며, PAD는 말초 동맥, 일반적으로 다리의 동맥이 좁아져 통증과 이동 문제를 유발하는 것이 특징입니다. 풍선이나 스텐트를 이용한 혈관 내 치료는 이러한 동맥을 재통과시켜 혈류를 회복시켜 증상을 완화하는 데 도움이 됩니다. 혈관외과에서는 동맥류 치료에 있어 이식편이나 혈관 내 동맥류 치료(EVAR) 시스템과 같은 기구가 필수적입니다. 동맥류는 혈관벽이 부풀어 오르거나 약해진 부분으로, 제대로 관리하지 않으면 파열될 수 있습니다. 또한, 말초혈관 기기는 DVT와 같은 정맥 질환 관리에 필수적이며, 혈전 제거 장치와 필터는 폐색전증과 같은 생명을 위협하는 합병증을 예방합니다. 다양한 혈관 질환에 대응하는 이들 기기의 다양성과 유효성은 현대 의료 현장에서 그 중요성을 강조하고 있습니다.

말초혈관 기기 시장의 성장을 가속하는 요인은 무엇인가?

말초혈관 기기 시장의 성장은 여러 요인에 의해 주도되고 있습니다. 중요한 촉진요인 중 하나는 심혈관 질환 및 말초혈관 질환의 위험을 증가시키는 당뇨병, 고혈압과 같은 생활습관병의 유병률 증가입니다. 또한, 혈관 장치의 안전성과 유효성을 향상시키는 기술의 발전은 치료 가능한 질환의 범위를 넓히고 환자의 예후를 개선하여 시장 성장을 가속하고 있습니다. 또한, 고령자는 혈관 질환에 걸리기 쉽기 때문에 전 세계 인구의 고령화가 시장 확대에 기여하고 있습니다. 기존 수술에 비해 회복 시간이 짧고 합병증이 적은 최소 침습 수술에 대한 수요가 증가함에 따라 이러한 장비의 채택을 더욱 촉진하고 있습니다. 또한, 신흥 시장의 의료비 지출 증가와 첨단 의료 기술에 대한 접근성 향상으로 새로운 성장 기회가 창출되고 있습니다. 이러한 요인들이 복합적으로 작용하여 말초혈관 기기 시장은 혁신적이고 효과적인 혈관 치료에 대한 지속적인 수요에 힘입어 견조한 성장세를 보이고 있습니다.

부문

디바이스 유형(혈관성형술용 스텐트, 혈관성형술용 풍선, EVAR 스텐트 그래프트, 카테터, 플라크 수정 디바이스, 혈행 동태 변경 디바이스, 하대정맥 필터, 기타 디바이스 유형)

조사 대상 기업 예

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.07.15

Global Peripheral Vascular Devices Market to Reach US$16.0 Billion by 2030

The global market for Peripheral Vascular Devices estimated at US$12.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Angioplasty Balloon segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 3.6% CAGR

The Peripheral Vascular Devices market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Vascular Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Peripheral Artery Disease (PAD) Propels Growth in Peripheral Vascular Devices Market
    • Advances in Minimally Invasive Techniques Strengthen Business Case for Peripheral Vascular Devices
    • Increasing Adoption of Drug-Eluting Stents and Balloons Drives Market Growth
    • Expansion of Endovascular Procedures Generates Market Opportunities
    • Technological Innovations in Imaging and Navigation Systems Enhance Market Potential
    • Growing Geriatric Population Sustains Demand for Peripheral Vascular Interventions
    • Increasing Focus on Patient Safety and Outcomes Spurs Market Adoption
    • Development of Biodegradable and Bioabsorbable Devices Expands Addressable Market
    • Growing Awareness of Peripheral Vascular Diseases Spurs Market Demand
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
    • Increasing Investments in Healthcare Infrastructure Drive Adoption of Peripheral Vascular Devices
    • Expansion of Peripheral Vascular Device Applications in Emerging Markets Propels Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Vascular Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Angioplasty Balloon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EVAR Stent Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Inferior Vena Cava Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CHINA
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: France 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Germany 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Italy 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: UK 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of World 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제